Clopidogrel improves endothelial function and NO bioavailability by sensitizing adenylyl cyclase in rats with congestive heart failure

Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure

(2010) Andreas Schäfer et al.   PHARMACOLOGICAL RESEARCH

Diastolic heart failure: a misNOmer

(2009) Gerd Heusch   BASIC RESEARCH IN CARDIOLOGY

Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve

(2009) Gerd Heusch   BASIC RESEARCH IN CARDIOLOGY

The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury

(2009) S. Frantz et al.   BASIC RESEARCH IN CARDIOLOGY

Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes

(2009) Philipp Diehl et al.   BASIC RESEARCH IN CARDIOLOGY

Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure

(2009) Dirk Westermann et al.   BASIC RESEARCH IN CARDIOLOGY

Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer

(2009) Andreas Schäfer et al.   EUROPEAN JOURNAL OF HEART FAILURE

Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved

(2008) Mario Lorenz et al.   BASIC RESEARCH IN CARDIOLOGY

A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: Results of a double-blind, randomized study

(2007) Ascan Warnholtz et al.   ATHEROSCLEROSIS

Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta

(2005) Pieter-Jan D F Guns et al.   BRITISH JOURNAL OF PHARMACOLOGY